Trexquant Investment LP Cyma Bay Therapeutics, Inc. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$10.86 - $17.62 $1.77 Million - $2.88 Million	163,278 Added 289.11%	219,755 $3.28 Million
Q2 2023 Aug 11, 2023	SELL	$7.47 - $10.95 $55,345 - $81,128	-7,409 Reduced 11.6%	56,477 $618,000
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $375,649 - $612,666	63,886 New	63,886 $557,000
Q1 2021 May 13, 2021	SELL	$4.23 - $6.55 $222,899 - $345,152	-52,695 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$5.73 - $9.03 $301,942 - $475,835	52,695 New	52,695 $302,000
Q2 2019 Aug 09, 2019	SELL	$6.05 - $13.66 $71,353 - $161,106	-11,794 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$8.16 - $13.42 $96,239 - $158,275	11,794 New	11,794 $157,000
Q1 2018 May 03, 2018	SELL	$9.0 - $15.16 $202,599 - $341,266	-22,511 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$7.67 - $9.31 $172,659 - $209,577	22,511	22,511 $207,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.